Exploring how cerebellar stimulation affects cognitive sequencing
Official title: Investigation of Cerebellar Involvement in Cognitive Sequencing
Run by Johns Hopkins University · NCT06108336 · Data updated 2026-11-12
This study is testing if stimulating a part of the brain called the cerebellum can help people improve their ability to complete tasks that require following a sequence.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | December 30, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT06108336 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are right-handed individuals aged 18-50 with at least 8 years of education who are fluent in English.
✕Probably not a fit
Patients with neurological disorders, psychiatric conditions, or those on certain medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the role of the cerebellum in cognitive functions, particularly its involvement in sequencing tasks. By using transcranial magnetic stimulation (TMS), researchers will assess brain activation during both sequence-demanding and non-sequence-demanding tasks. The study aims to clarify how cerebellar stimulation influences cognitive processing and whether it can enhance performance in tasks that require sequencing. Participants will undergo functional MRI scans to observe brain activity in response to different stimulation conditions.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for cognitive impairments related to sequencing and memory.
How similar studies have gone: While the role of the cerebellum in cognition is increasingly recognized, this specific approach using TMS for cognitive sequencing is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\) Age 18-50; * 2\) educational attainment of at least 8 years; * 3\) capable of giving informed consent; * 4\) fluent speaker of English by self-report; * 5\) right handed. Exclusion Criteria: * 1\) illicit drug use within 30 days of MRI scanning; * 2\) neurological or systemic disorder which can cause dementia or cognitive dysfunction; * 3\) history of an Axis I psychiatric disorder including substance use disorder; * 4\) history of definite stroke; * 5\) focal lesion on MRI exam; * 6\) uncorrected visual deficits by self-report * 7\) contraindications for MRI scanning * 8\) use of anxiolytic, antidepressant, neuroleptic, or sedative medication * 9\) Additional exclusion criteria recommended by Wassermann for TMS neuromodulation, including: History of seizure or a family history of epilepsy, heart disease, intracardiac lines, increased intracranial pressure, history of head trauma, and history of respiratory disease
Where it's running
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: John E Desmond, Ph.D. — Johns Hopkins University
- Study coordinator: John E Desmond, Ph.D.
- Email: jdesmon2@jhmi.edu
- Phone: 410-502-3583
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Psilocybin-assisted therapy to help adults with amblyopia see more clearly
This study tests whether a single or small doses of psilocybin can boost the effectiveness of amblyopia treatment in adults.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Social Connection Collective for older adults in subsidized housing
A resident-led program in subsidized housing in Baltimore will try to build friendships and peer support among residents aged 62 and older to see if it’s feasible and if it reduces loneliness.
-
Oral Food Challenge After Starting Omalizumab in Food Allergy
This trial tests whether omalizumab begins to help with food allergy within 2 to 4 weeks after starting treatment in people with a confirmed food allergy.
-
Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
-
Impact of Patient Position on EndoFLIP Measurements in Kids and Young Adults
This study tests whether EndoFLIP measurements differ when patients are in the supine versus left-side position during the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.